Skip to main content
J Michael Mcintosh, MD, Psychiatry, Salt Lake City, UT, George E. Wahlen Department of Veterans Affairs Medical Center

J MichaelMichaelMcintoshMD

Psychiatry Salt Lake City, UT

Psychosomatic Medicine

Psychiatrist/ VA Hospital

Dr. Mcintosh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mcintosh's full profile

Already have an account?

Education & Training

  • University of Utah Health
    University of Utah HealthFellowship, Psychosomatic Medicine, 1991 - 1992
  • University of Colorado
    University of ColoradoResidency, Psychiatry, 1987 - 1991
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1987
  • University of Utah
    University of UtahB.S., Biology, 1979 - 1983

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 1991 - 2026
  • WY State Medical License
    WY State Medical License 1995 - 2006
  • CO State Medical License
    CO State Medical License 1989 - 1991
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Marquis Who's Who in America 2013
  • America's Top Doctors 2010
  • Listed among top 20 psychiatrists U.S. in Men's Health Magazine, 2007
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Differential roles of alpha6beta2* and alpha4beta2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice  
    Sanjakdar SS, Maldoon PP, Marks MJ, Brunzell DH, Maskos U, McIntosh JM, Bowers MS, Damaj MI, Neuropsychopharmacology, 1/1/2015
  • The alpha7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions  
    Bordia T, McGregor M, Papke RL, Decker MW, McIntosh JM, Quik M, Exp Neurol, 1/1/2015
  • Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents  
    Kewin K, Jordan Cameron P, Klapczynski M, McIntosh JM, Crooks PA, Dwoskin LP, Lysakowski, J Neurosci, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • alpha-Conotoxin ImI, a selective ligand for neuronal nAChRs
    McIntosh JM, Johnson DS, Yoshikami D, Mahe E, Nielsen DB, Rivier JE, Gray WR, Olivera BM, International Symposium on Nicotine: The Effects of Nicotine on Biological Systems, Basel, Switzerland, 1/1/1994

Lectures

  • Nicotinic Acetylcholine Receptors as Therapeutic Targets 
    1/1/2010
  • Natrual Peptides to Drugs 
    Zurmatt, Switzerland - 1/1/2008
  • Nicotinic Acetylcholine Receptors 
    Cambridge UK - 1/1/2008
  • Join now to see all

Grant Support

  • Novel Nachr-Targeted PeptidesNational Institute Of Mental Health2011
  • Alpha-Conotoxin - Alpha9_alpha10 NachrsNational Institute Of General Medical Sciences2008–2011
  • Novel Neuronal Nachr-Targeted PeptidesNational Institute Of Mental Health2001–2010
  • Functional Structure Of Conotoxins Targeting Nicotinic Acetylcholine ReceptorNational Institute Of General Medical Sciences1998–2002
  • Novel Neuronal Nachr-Targeted PeptidesNational Institute Of Mental Health1996–2000
  • NMDA And Dopamine Receptors Using ConotoxinsNational Institute Of Mental Health1991–1995

Hospital Affiliations